Previous close | 0.5000 |
Open | 0.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 55.00 |
Expiry date | 2025-01-17 |
Day's range | 0.5000 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.